See also this year's filing and all EDGAR filings for this company.
PDF Report 0001356576_2020_SUPERNUS_PHARMACEUTICALS_INC.pdf
Logs
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0001356576, SUPERNUS PHARMACEUTICALS INC.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 472,644,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 24,840,000 |
| 2 | PropertyPlantAndEquipmentNet | 17,068,000 |
| 3 | remainder_Assets | 645,730,000 |
| 4 | LiabilitiesCurrent | 160,587,000 |
| 5 | LiabilitiesNoncurrent | 39,849,000 |
| 6 | remainder_Liabilities | 364,418,000 |
| 7 | CostOfGoodsAndServicesSold | 16,660,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 158,425,000 |
| 9 | ResearchAndDevelopmentExpense | 69,099,000 |
| 10 | remainder_Expenses | 34,431,000 |
| 11 | remainder_Revenues | 392,755,000 |
| 12 | remainder_NetIncome | -1,084,000 |
| 13 | remainder_ComprehensiveNetIncome | 10,575,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,160,282,000 |
| 1 | Liabilities | 564,854,000 |
| 2 | Expenses | 278,615,000 |
| 3 | Revenues | 392,755,000 |
| 4 | StockholdersEquity | 595,428,000 |
| 5 | NetIncome | 113,056,000 |
| 6 | ComprehensiveNetIncome | 118,343,500 |
| 7 | BaseVar | 1,204,082,500 |
| 8 | EconomicCapitalRatio | 1.32 |
Edgar->Model Mapping
Feature Distribution
Change over Time
